At a glance
- Originator Novartis
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 27 Aug 2003 Discontinued - Preclinical for Pain (PO)
- 13 Jun 2001 No-Development-Reported for Pain (PO)
- 24 Jun 1998 Preclinical development for Pain (PO)